Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Oct 20, 2022 6:38pm
172 Views
Post# 35037699

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Truist??

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Truist??A lot of followers on Stocktwits have dropped off over the last few days.  There was huge volume after the ZipTrader promotion.  I've been waiting for that to sell off harder than it has felt like it has.  Maybe today was a good chunk of that.  THTX didn't take advantage of all those new followers.  They didn't enhance the story, and they left everyone guessing.  I do think they've at least tried to build on the story with the more recent PR"s, but it appears they did too much damage to the investor base and the stock is going to simply languish until big news comes out to de-risk oncology.  I guess I'll go back into the hollows of dispair while I wait on the flip of the coin as to if this is going to work or not.  I just think people are giving up and moving on.  It feels even longer of a wait when there's no expectation of anything meaningful coming out until all known variables are understood by the company.  Oh well!  All or nothing, all-in, baby!  Ride or die!  Let's go!

SPCEO1 wrote: C$0.19 on 9/30/13. It is hard to see us getting near that again but in a big bear  market blowout with lots of margin calls, anything is possible for  ashort preiod of time before order is restored. Of course, if you note the all time low, it seems only fair to note the all-time high of C$14.75 just 4.5 years ago (actually it got to $15.95 on 2000). The stock could easily get back there again and more if cancer works out well.

muslix1 wrote: Biobob ...welcome to the pleasuredome
we could go to 1$ .. i remember 2013 ..0,30$ cnd...
keep the faith or GO




<< Previous
Bullboard Posts
Next >>